Brief: Aridis Pharmaceuticals And Hepalink Entered Amendment To JV Agreement

Shenzhen Hepalink Pharmaceutical Co

30/08/2018 21:42

Aug 30 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd
 002399.SZ :
    * ARIDIS PHARMACEUTICALS -  ON AUG 24, CO AND HEPALINK
ENTERED
AMENDMENT TO JV AGREEMENT 
    * ARIDIS PHARMACEUTICALS-PURSUANT TO AMENDMENT, CO TO GRANT
AR-105
PRODUCT CANDIDATE LICENSE TO SABC, HEPALINK TO CONTRIBUTE
ADDITIONAL $1.2 MILLION TO SABC
    * ARIDIS PHARMACEUTICALS - PURSUANT TO JV AGREEMENT AND
AMENDMENT,
HEPALINK IS OBLIGATED TO CONTRIBUTE EQUIVALENT OF $7.2 MILLION
TO SABC

Source text: (https://bit.ly/2C48xOS)
Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))